Diasorin | DIA - Cost Of Sales

Stock Price
64.63
Daily Change
1.01 1.59%
Monthly
-7.96%
Yearly
-31.95%
Q1 Forecast
62.02

Diasorin reported EUR99.64M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amplifon EUR 460.17M 14.78M Sep/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Brookdale Senior Living USD 643.31M 41M Dec/2025
Cencora USD 83.12B 2.35B Dec/2025
Diasorin EUR 99.64M 4.71M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Enovis USD 271.52M 7.83M Dec/2025
GE HealthCare Technologies USD 3.44B 283M Dec/2025
OPKO Health USD 103.48M 1.3M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025